Affordable Access

deepdyve-link
Publisher Website

Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).

Authors
  • Hagelstein, V1
  • Ortland, I1
  • Wilmer, A1
  • Mitchell, S A2
  • Jaehde, U3
  • 1 Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn, Germany. , (Germany)
  • 2 Division of Cancer Control and Population Sciences, Outcomes Research Branch, National Cancer Institute, Rockville, USA.
  • 3 Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn, Germany [email protected] , (Germany)
Type
Published Article
Journal
Annals of Oncology
Publisher
Oxford University Press
Publication Date
Dec 01, 2016
Volume
27
Issue
12
Pages
2294–2299
Identifiers
DOI: 10.1093/annonc/mdw422
PMID: 27681863
Source
Medline
Keywords
License
Unknown

Abstract

A set of 31 items drawn from the German PRO-CTCAE item library demonstrated favourable measurement properties. These findings add to the body of evidence that PRO-CTCAE provides a rigorous method to capture patient self-reports of symptomatic toxicity for use in cancer clinical trials.

Report this publication

Statistics

Seen <100 times